1Winer EP, Morrow M, Osborne CK, et al. Malignant Tumors of the Breast. In:Devita VT eds. Cancer: principles and Practice of Oncology, 6th ed. Philadelphia: Lippincott Williams & Wilkins,2001.1557-1605.
2Barker JL, Montague ED, Peters LJ. Clinical experience with irradiation of inflammatory carcinoma of the breast with and without elective chemotherapy. Cancer,1980,45:625-629.
3Giannakakis D, Koukourakis M, Sotiropoulou A, et al. Accelerated hyperfractionation of radiotherapy for rapidly growing inoperable breast cancer unresponsive to chemotherapy. Tumori,1992,78:326-329.
4Thoms WW, McNeese MD, Fletcher GH, et al. Multimodality treatment for inflammatory breast cancer. Int J Radiat Oncol Biol Phys,1989,17:739-745.
5Ballo MT, Strom EA, Prost H, et al. Local-regional control of recurrent breast carcinoma after mastectomy: does hyperfractionated accelerated radiotherapy improve local control Int J Radiat Oncol Biol Phys,1999,44:105-112.
6Schomberg PJ, Shanahan TG, Ingle JN, et al. Accelerated hyperfractionation radiation therapy after lumpectomy and axillary lymph node dissection in patients with stage Ⅰ or Ⅱ breast cancer: pilot study. Radiology,1997,202:565-569.
7Fletcher GH. Hypofractionation:lessons from complications. Radiother Oncol,1991,20:10-15.
8Thames HD, Bentazen SM, Turesson I, et al. Time-dose factors in radiotherapy: a review of the human data. Radiother Oncol,1990,19:219-235.
9Hall EJ. Time, dose, and fractionation in radiotherapy. In: Hall EJ, eds. Radiobiology for the Radiologist. Philadelphia: Lippincott Williams & Willkins,2000.409-415.
10Eifel P, Axelson JA, Costa J, et al. National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst,2001,93:979-989.
二级参考文献14
1Baillet F, Housset M, Maylin C, et al. The use of a specific hypofractionated radiation therapy regimen versus classical fractionation in the treatment of breast cancer: a randomized study of 230 patients. Int J Radiat Oncol Biol Phys, 1990, 19: 1131-1133.
2McCormick B, Strom E, Craighead PS, et al. Radiation Therapy Oncology Group. Research Plan 2002-2006. Breast Cancer Working Group. Int J Radiat Oncol Biol Phys, 2001,51 (3 suppl 2): 56-57.
3Kiricuta CI, Tausch J. A mathematical model of axillary lymph node involvement based on 1446 complete axillary dissections in patients with breast carcinoma. Cancer, 1992; 69: 2496-2501.
4Iyer RV, Hanlon AL, Fowble B, et al. Accuracy of the extent of axillary nodal positivity related to primary tumor size, number of involved nodes and number of nodes examined. Int J Radit Oncol Biol Phys,1999, 45(3 Suppl): 155-156.
5Yamada Y, Ackerman I, Franssen E, et al. Dose the dose fractionation schedule influence local control of adjuvant radiotherapy for early stage breast cancer? Int J Radiat Oncol Biol Phys,1999, 44: 99-104.
6Svoboda VH, Krawczyk J, Krawczyk A. Seventeen years experience with accelerated radiotherapy for carcinoma of the breast. Int J Radiat Oncol Biol Phys, 1992, 24: 65-71.
7Whelan TJ, Julian J, Wright J, et al. Does local radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol, 2000, 18: 1220-1229.
8Eifel P, Axelson JA, Costa J, et al. National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst. 2001, 93:979-989.
9Fowble B. The role of postmastectomy adjuvant radiotherapy for operable breast cancer. In: Fowble B, Goodman RL, Glick JG, eds. Breast cancer treatment a comprehensive guide to management. 1st ed. ST. Louis: Mosby-Year Book. 1991.289-309.
10Goel A, Kaushal V, Hooda HS,et al. Comparison of two radiation dose schedules in post mastectomy carcinoma of the breast. Indian J Med Sci, 2000, 54:278-283.
3Parkin D M, Bray F, Ferlay J, et al. Global cancer statistics, 2002 [J]. CA Cancer J Clin, 2005,55(2):74-108.
4Violet J A, Harme R C. Breast cancer:improving outcome following adjuvant radiotherapy [J]. Br J Radiol, 2004,77(922) :811-820.
5Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourabl effects on long-terms survival of radiotherapy for early breastc ancer: an overview of the randomized trials [J]. Lancet, 2000,355 (9127 ) : 1757 - 1770.
6Obedian R, Haffry B G. Internal mammary nodal irradiation in conservatively-managed breast cancer patients: Is them a benefit [J] ? Int J Radiat Oneol Biol Phys, 1999,44(5):997-1005.
7Hiraoka M, Mitsumori M, Shibuya K. Adjuvant radiation therapy following mastectomy for breast cancer [Jl. Breast Cancer, 2002,9 (3) : 190-195.
8Fodor J, Polgar C, Major T, et al. Locoregional failure 15 years after mastectomy in women with one to three positive axilary nodes with or without irradiation the significance of tumor size [ J ]. Strahlenther Onkol, 2003,179(3) : 197-201.
9Mcevoy S P, Ingram D M, Byrne M J, et al. Breast cancer in Western Australia clinical practice and clinical guidelines [J]. Med J Aust, 2004,181 ( 6 ) : 305-309.
10Fodor J, Major T, Polgar C, et al. The impact of radiotherapy on the incidence and time of occurrence of local recurrence in early-stage breast cancer after breast conserving therapy [J]. Neoplasma, 2000, 47(3) : 181-186.
